Close Menu

NEW YORK – Molecular diagnostics firm Vikor Scientific has made a strategic investment in California-based Quantgene to accelerate the commercialization of Quantgene's Serenity, a personalized preventive medicine service that includes the use of whole-genome sequencing, artificial intelligence-informed liquid biopsy cancer screening, and other in-depth health profiling.

The companies made the announcement on Wednesday during the SCBIO 2021 annual meeting. Financial details of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.